Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3335257 | Transfusion and Apheresis Science | 2012 | 4 Pages |
Abstract
Plerixafor in conjunction with G-CSF (G–P) is an effective strategy for hematopoietic stem cell mobilization in patients with previously failed mobilization attempt. Here we report our results with G–P among patients with at least one mobilization failure with G-CSF alone (G) or G-CSF plus chemotherapy (G–C). The study included 20 consecutive patients with lymphoma and myeloma from five centers. In 14 (70%) patients, a minimum of 2 × 106/kg CD34+ stem cells were collected and 16 out of 20 patients (80%) were able to proceed to ASCT. Our study indicates that plerixafor can safely rescue patients with a history of mobilization failure.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Emre Tekgündüz, Fevzi Altuntaş, Serdar Şıvgın, Şahika Zeynep Akı, Ayhan Dönmez, Pervin Topçuoğlu, Rahşan Yıldırım, Nuran Ahu Baysal, Erol Ayyıldız, Meltem Kurt Yüksel, İsmail Sarı, Murat Tombuloğlu, Ali Ünal, Osman İlhan,